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ApoptosisPoly(ADP-ribosyl)ation (PARylation) is a NAD+-dependent protein modiﬁcation carried out by PARP
[poly(ADP-ribose) polymerase] enzymes. Here we set out to investigate whether PARylation regulates
UVB-induced cell death in primary human keratinocytes. We used the benchmark PARP inhibitor
3-aminobenzamide (3AB) and a more potent and speciﬁc inhibitor PJ34 and found that UVB (0.05–0.2 J/cm2)
induced a dose dependent loss of viability that was prevented by 3AB but not by PJ34. Similarly to PJ34, two
other new generation PARP inhibitors also failed to protect keratinocytes from UVB-induced loss of viability.
Moreover, silencing PARP-1 in HaCaT human keratinocytes sensitized cells to UVB toxicity but 3AB provided
protection to both control HaCaT cells and to PARP-1 silenced cells indicating that the photoprotective effect
of 3AB is independent of PARP inhibition. Lower UVB doses (0.0125–0.05 J/cm2) caused inhibition of prolifera-
tion of keratinocytes which was prevented by 3AB but augmented by PJ34. UVB-induced keratinocyte death
displayed the characteristics of both apoptosis (morphology, caspase activity, DNA fragmentation) and necrosis
(morphology, LDH release)with all of these parameters being inhibited by 3AB and apoptotic parameters slightly
enhanced by PJ34. UVA also caused apoptotic and necrotic cell death in keratinocytes with 3AB protecting and
PJ34 sensitizing cells to UVA-induced toxicity. 3AB prevented UVB-induced mitochondrial membrane depolari-
zation and generation of hydrogen peroxide. In summary, PARylation is a survival mechanism in UV-treated
keratinocytes. Moreover, 3-aminobenzamide is photoprotective and acts by a PARP-independent mechanism
at a premitochondrial step of phototoxicity.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
The human skin is exposed to solar ultraviolet radiation which
contributes to the increasing incidence of skin tumors such as basal
and squamous cell carcinoma and melanoma [1,2]. Whereas the
short wavelength UVC is effectively ﬁltered out by the ozone layer,
UVB and UVA reach the Earth surface and get absorbed in the skin.
The biological effects of UV radiation in the skin depend on the type
and dose of UV radiation (UVR) and range from the induction of
pigmentation, vitamin D synthesis and immunosuppression to photo-
aging and carcinogenesis [3,4]. In addition to amino acids, various
metabolites and trans-urocanic acid, DNA is also among the molecules
absorbing the energy of UV radiation in the skin [5]. UV-induced
photoproducts such as cyclobutane pyrimidine dimers (CPD) and 6–4mistry, University of Debrecen,
, H-4032 Debrecen, Hungary.
rights reserved.photoproducts as well as oxidative stress-induced secondary products
such as 8-oxo-deoxyguanine activate DNA repair, apoptosis (sunburn
cell formation) and mediate immunosuppression and inﬂammation
[5,6].
Poly(ADP-ribosyl)ation (PARylation) is aNAD+-dependent covalent
proteinmodiﬁcation [7] thatmay regulate the biological response of the
skin to UVR. PARylation is carried out by poly(ADP-ribose) polymerase
(PARP) enzymes with PARP-1 and PARP-2 being the most prominent
DNA break-activatedmembers of the PARP family. The nuclear proteins
PARP-1 and PARP-2 are important DNA damage sensors and upon bind-
ing to broken DNA they cleave NAD+ into nicotinamide and ADP-ribose
and covalently attach the latter to themselves (auto-PARylation) or to
other suitable target proteins (trans-PARylation). By repeated NAD+
cleavage and ADP-ribose attachment they elongate the chain to form
a branched PAR polymer [7,8]. PAR is rapidly degraded by PAR
glycohydrolase (PARG) [9,10]. Reversible PARylation is now recognized
as an important form of posttranslational protein modiﬁcation mediat-
ing various cellular processes ranging from DNA repair, transcriptional
regulation and protein turnover to various forms of cell death [7,10–12].
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[13]. PARP-1 is an important mediator of contact hypersensitivity as
indicated by the anti-inﬂammatory effects of PARP inhibition or the
PARP-1−/− phenotype [14,15]. Furthermore, sulfur mustard-induced
vesication was proposed to be mediated by PARP activation [16].
Moreover, differential expression of PARP-1 and the PAR polymer
in malignant melanomas has been shown to correlate with the
clinical stage and disease-free survival of the patients [17,18]. However,
little information is available on the role of PARylation in the regulation
of the UV response in keratinocytes. Here we show that only very
high doses (2–4 J/cm2) of UVB activate PARP in human keratinocytes.
Interestingly, the benchmark PARP inhibitor 3-aminobenzamide pro-
tected keratinocytes fromUVB andUVA-induced apoptotic and necrotic
cell death but this protective effect was independent of PARP inhibition
and is related to prevention ofmitochondrial dysfunction and inhibition
of ROS (reactive oxygen species) production.
2. Materials and methods
2.1. Cell culture
Cryopreserved normal human keratinocytes were purchased
from CELLnTEC (Bern, Switzerland), and cultured in PCT Epidermal
Keratinocyte Medium (low bovine pituitary extract and low calcium
formulation) supplemented with 5% penicillin-streptomycin (Lonza,
Basel, Switzerland). Cells were maintained at 37 °C in a humidiﬁed
atmosphere (5% CO2), and were passaged at 80–90% conﬂuency
after trypsinization with trypsin–EDTA solution (Sigma-Aldrich, St.
Louis, MO). Second and third passage cells were used for experiments.
HaCaT spontaneously immortalized keratinocyte cellswere cultured
in DMEM (Sigma-Aldrich, St. Louis, MO) supplemented with 10% heat-
inactivated fetal bovine serum, 5% penicillin-streptomycin (Lonza,
Basel, Switzerland) and 5%, L-glutamine.
2.2. Gene silencing
SMARTpool siRNA speciﬁc for human PARP-1 sequence was
obtained from Dharmacon Research, Inc. (Lafayette, CO). SiGLO
RISC-Free siRNA (Dharmacon) was used as control. HaCaT cells
were seeded into 12-well plates (2×105 cells/well) and into 96
well plates (5000 cells/well) the day before transfection in DMEM
containing 10% FBS without antibiotics. DharmaFECT 2 transfection
reagent (Dharmacon) was diluted 1:100 in serum free DMEM and
incubated at room temperature for 5 min. In parallel, 10 μM siRNA
in 1× siRNA buffer (Dharmacon) was diluted 1:1 in serum-free
DMEM and were incubated for 20 min at room temperature prior
to addition to cells with a ﬁnal siRNA concentration of 50 nM. After
72 h, the medium was replaced with complete growth medium.
After another 24 h, efﬁciency of silencing was determined from
12-well plates by Western blotting [19] and cells in 96-well plates
were used for the viability assay.
2.3. Cell treatments and UV irradiation
In the experiments the cells were pretreated for 30 min with
two different PARP inhibitors, 10 μM PJ34 (Inotek Corporation,
Beverly, MA) and 3 mM 3-aminobenzamide (Sigma-Aldrich,
St. Louis, MO). In one experiment other potent PARP inhibitors
thieno[2,3-c]isoquinolin-5-one (TIQ-A) and 3,4-dihydro-5-[4-(1-
piperidinyl)butoxyl]-1(2H)-isoquinolinone (DPQ) (all of them
purchased from Axxora, Lause, Switzerland) were also used in
10 μM concentration. The cells were irradiated with the Bio-Sun
microprocessor-controlled UV irradiation system (Wilber Lourmat,
Marne-la-Vallée, France). The equipment operates at twowavelengths:
312 nm (UVB) and 365 nm (UVA) and is equipped with a built-in UV
sensor. The irradiation stops automatically when the energy receivedmatches the programmed energy. The primary keratinocytes were irra-
diated in the culture medium with different doses of UVB (0.05 J/cm2–
0.2 J/cm2) and UVA (1.5–6 J/cm2) in uniform depth of medium (7 mm
in 96well plates, 5 mm in 24well plates and 3.3 mm in 6well plates).
The effect of the depth of irradiation medium on UV-induced cell
death was determined but was found to have no effect on cell surviv-
al in the range of 1.8–12 mm. For the determination of PARP activa-
tion, higher doses (2–4 J/cm2) were also used, whereas for the
proliferation assay, lower doses of UVB (0.0125–0.05 J/cm2) have
also been applied. The lid was removed from the plates before irradi-
ation. Irradiation of HaCaT cells was carried out in phenol red free
medium.
2.4. Cell viability and proliferation assay
Cell viability was determined with the MTT assay as previously
described [20]. For the cell proliferation assay keratinocytes were
grown to 70–80% conﬂuency. Cells were then trypsinized, resuspended
in the media, and counted. The cells were reseeded into 6-well tissue
culture plates (2500 per well). After the pretreatment with PJ34 and
3AB and irradiation with UVB, the cells were incubated for 10 days.
Fresh medium was added immediately after the irradiation, and on
day 5. On day 10, medium was removed from the wells and cells were
washed oncewith PBS. Half of the wells were stained with hematoxylin
(Sigma-Aldrich, St. Louis, MO) for microscopic evaluation and the
other half was stained for viability with MTT (Sigma-Aldrich, St.
Louis, MO). hematoxylin-stained samples were photographed whereas
MTT-stained samples were used for the quantiﬁcation of cell prolife-
ration (absorbance was measured at 590 nm after solubilization of the
formazan crystals in DMSO).
2.5. LDH release assay
Lactate dehydrogenase released from damaged cells was measured
with a commercial kit (Roche Applied Science, Mannheim, Germany).
Brieﬂy,microplateswere centrifuged at 250 g for 10 min and the super-
natants (100 μl) were transferred to 96-well ﬂat bottom plates. Detec-
tion reagent (100 μl) was added, plates were incubated (30 min) and
the absorbance of samples was measured at 490 nm.
2.6. Detection of caspase activation
Caspase-3 like activity was assessed by immunocytochemical
detection of cleaved PARP-1 as detailed in Section 2.7.
2.7. Immunocytochemistry
PAR and cleaved PARP-1 were detected by immunocytochemistry.
Cells were ﬁxed in ice-cold methanol for 10 min at−20 °C and were
rehydrated with 4 washes in PBS. After blocking endogenous peroxi-
dase with 0.5% H2O2 in methanol, non-speciﬁc binding was blocked
by incubating coverslips in 1% BSA/PBS for 1 h. The cells were incu-
bated for 1.5 h at room temperature with the primary antibodies: a
monoclonal anti-PAR antibody (clone 10H, in 1:500 dilution) and a
monoclonal cleaved hPARP-1 (Cell Signaling Technology, Danvers,
MA, in 1:100 dilution). After 4×5 minwashes in PBS, coverlips were in-
cubated for 30 min at room temperature with peroxidase-conjugated
rabbit/mouse secondary antibody (REAL Envision Detection System,
Dako, Glostrup, Denmark). After washes, the peroxidase reaction was
developed with 3,3-diaminobenzidine (DAB) substrate. Coverslips
were viewed with a Zeiss Axiolab microscope (Carl Zeiss, Oberkochen,
Germany). Pictures were taken with a Zeiss Axiocam digital camera.
Samples processed with omission of the primary antibody served as
negative control in the cleaved PARP-1 staining, whereas in the PAR
staining the effect of PARP inhibitor treatment proved the speciﬁcity
of the staining.
Fig. 1. Opposing effects of PJ34 and 3AB on UVB-induced keratinocyte death and proliferation inhibition. (A) NHEK were either left untreated or were pretreated with 10 μM PJ34 or
3 mM 3AB for 30 min followed by irradiation with the indicated doses of UVB. After 24 h incubation, viability was determined with MTT assay. UVB induced a time- and
dose-dependent loss of viability. 3AB protected cells from UVB-induced cell death. (B) The proliferative capacity was determined in clonogenic assay. Ten days after UVB irradiation
NHEK cells were stained with hematoxylin. (C) The number of viable cells was also determined with MTT assay. UVB treatment resulted in inhibition of proliferation. Whereas PJ34
sensitized cells to the antiproliferative effect of UVB, 3AB provided protection from UVB-induced cytostasis. Data on panels “A” and “C” represent mean±SE of three independent
experiments using keratinocytes from different donors. Stars represent statistically signiﬁcant (*pb0.05, **pb0.01, ***pb0.001) difference between control and UVB-irradiated cells
whereas “#” symbols indicate statistically signiﬁcant (#pb0.05, ##pb0.01, ###pb0.001) effects of 3AB or PJ34 on the UVB-induced response. Representative images are shown on
panel “B”.
745P. Lakatos et al. / Biochimica et Biophysica Acta 1833 (2013) 743–7512.8. Mitochondrial membrane potential
The cells were seeded (2×106/ml) into black 96-well plates. After
the pretreatment and UVB irradiation, the incubation time was 24 h.
Then the cells were loaded with 100 nM tetramethylrhodamine
ethyl ester, TMRE, (Sigma-Aldrich, St. Louis, MO) for 20 min at 37 °C.
Cells were then washed with PBS, and TMRE ﬂuorescence was mea-
sured with a ﬂuorescence spectrophotometer (Fluoroskan FL, Thermo
Scientiﬁc, Vantaa, Finland; ex 535 nm; em 590 nm).
2.9. Hydrogen peroxide production
Hydrogen peroxide production was determined with a ﬂuorometric
Amplex red assay kit (Invitrogen, Carlsbad, CA) following the instructions
of themanufacturer. Cellswereﬁrst irradiatedwithUVBor UVA followed
by the addition of Amplex Red reagent (50 μM) and horse radish perox-
idase (0.1 U/ml, Sigma-Aldrich). After incubation (30 min, 37 °C), the
ﬂuorescence was measured with a ﬂuorescence spectrophotometer
(Fluoroskan FL, Thermo Scientiﬁc, Vantaa, Finland; ex 530 nm; em
590 nm).2.10. Statistical analysis
All experiments were performed three times on different days.
All the values shown on ﬁgures are expressed as mean±S.E. of the
mean of n observations where n represents the number of observa-
tions. Intergroup comparisons involved one-way ANOVA followed
by Tukey's test (with equal variances assumed) or Dunnett's test
(with equal variances not assumed). A p value less than 0.05 was
considered as signiﬁcant.
3. Results
3.1. Opposing effects of PJ34 and 3-aminobenzamide on UVB-induced
toxicity
First we demonstrated that UVB (0.05–0.2 J/cm2) caused a signif-
icant cytotoxicity in keratinocytes as determined in MTT viability
tests (Fig. 1A). We set out to investigate the role of PARylation in
UVB-induced keratinocyte death. Interestingly, only the benchmark
PARP inhibitor 3AB but not the more potent PJ34 provided protection
Fig. 2. 3AB inhibits UVB-induced apoptosis and necrosis. NHEK cells were either left untreated or were pretreated with 10 μM PJ34 or 3 mM 3AB for 30 min followed by irradiation
with the indicated doses of UVB. (A) After 24 h cells were stained with May-Grünwald–Giemsa for general morphology. (B) Immunostaining for cleaved PARP-1, a marker of
caspase activity, was also performed. Representative images are shown on panel “B”. Negative control samples were stained with the omission of the primary antibody. (C) Super-
natants were collected 24 h after the pretreatment and UVB irradiation and activity of released LDH was determined. 3AB prevented UVB-induced plasma membrane injury
(a marker of necrotic cell death) at all UVB doses. Data are presented as mean±SE of three independent experiments using keratinocytes from different donors. Stars represent
statistically signiﬁcant (*pb0.05, **pb0.01, ***pb0.001) difference between control and UVB-irradiated cells whereas “#” symbols indicate statistically signiﬁcant (#pb0.05,
##pb0.01, ###pb0.001) effects of 3AB or PJ34 on the UVB-induced response.
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0.1 J/cm2, PJ34 slightly sensitized cells to UVB-induced cell death
(Fig. 1A). The protection provided by 3AB was long lasting and
cells saved by pretreatment with 3AB have not simply survived
but maintained proliferative capacity as determined in long-term
(10 days) proliferation assay (Fig. 1B,C). As opposed to the protec-
tive effect of 3AB, the potent and speciﬁc PARP inhibitor PJ34 sensi-
tized cells to UVB-induced proliferation inhibition (Fig. 1B, C).3.2. 3-Aminobenzamide inhibits both apoptotic and necrotic cell death in
UVB-irradiated keratinocytes
In severe oxidative stress models, activation of PARP-1 has been
shown to switch apoptotic cell death towards necrosis [20,21].
Here we have also investigated whether PARylation regulates the
mode of cell death in UVB-treated keratinocytes. Morphology of
May-Grünwald–Giemsa stained cells indicated that 0.2 J/cm2 UVB
Fig. 3. 3AB inhibits UVB-induced ROS production and mitochondrial dysfunction. NHEK cells were either left untreated or were pretreated with 10 μM PJ34 or 3 mM 3AB for 30 min
followed by irradiation with the indicated doses of UVB. (A) Hydrogen peroxide production was determined after 60 min with Amplex red assay, and (B) mitochondrial inner mem-
brane depolarization was assayed with the TMRE ﬂuorescence method after 24 h. 3AB inhibited hydrogen peroxide production and prevented mitochondrial membrane depolar-
ization. PJ34 had no effect on these parameters with the exception of a slight but statistically signiﬁcant protection from mitochondrial depolarization induced by 0.2 J/cm2 UVB.
Data are presented as mean±SE of three independent experiments using keratinocytes from different donors. Stars represent statistically signiﬁcant (*pb0.05, **pb0.01,
***pb0.001) difference between control and UVB-irradiated cells whereas “#” symbols indicate statistically signiﬁcant (#pb0.05, ##pb0.01, ###pb0.001) effects of 3AB or PJ34
on the UVB-induced response.
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picnotic nuclei (Fig. 2A). PJ34 sensitized cells to UVB-induced cell
death as morphological alterations such as condensed apoptotic
cells and also swollen necrotic cells appeared at lower UVB dose
(0.1 J/cm2). Pretreatment of cells with 3AB prevented these mor-
phological alterations (Fig. 2A). Activity of caspases-3-like proteases,
general executioners of apoptosis could be clearly demonstrated by
immunodetection of cleaved PARP-1 (Fig. 2B). PJ34 sensitized cells
to apoptosis, whereas 3AB prevented it (Fig. 2). Increased plasma
membrane permeability as indicated for example by LDH release is
a sign of necrotic cell death. UVB treatment caused a dose-dependent
LDH release from keratinocytes (Fig. 2C) which showed an overlapping
patternwith the loss of viability (Fig. 2C).Whereas PJ34 had no effect on
LDH release, pretreatment with 3AB completely abolished plasma
membrane disruption (Fig. 2C).
3.3. 3-Aminobenzamide prevents mitochondrial dysfunction in UVB-
irradiated keratinocytes
UVB induces ROS production leading to mitochondrial dysfunction
(Kulms and Schwart 2002). Here we show that UVB radiation trig-
gered the production of hydrogen peroxide as determined in the
Amplex red assay (Fig. 3A). Moreover, UVB also induced mitochondri-
al depolarization (Fig. 3B). Both H2O2 production and the mitochon-
drial alterations were effectively blocked by 3AB but were not (or only
very slightly) affected by PJ34 (Fig. 3).
3.4. The protective effect of 3-aminobenzamide is PARP independent
In order to elucidate the mechanism for the differential effects of
the two PARP inhibitors we have also tested the effects of two
additional potent and speciﬁc PARP inhibitors TIQ-A and DPQ. Similarly
to PJ34, TIQ-A and DPQ also failed to protect keratinocytes fromUVB-induced toxicity (Fig. S1). In fact all three potent PARP inhibitors
slightly but signiﬁcantly sensitized cells to UVB-induced cell death
(Fig. S1).
Interestingly, PARP activity of irradiated cells as measured by
either the immunodetection of the PAR polymer (Fig. S2A) or by the
3H-NAD-based PARP enzyme assay (Fig. S2B) could only be observed
at UVB doses (2–4 J/cm2) much higher than the cytotoxic dose
(around 0.2 J/cm2). At lower doses PAR polymer was not detectable
(not shown). (Hydrogen peroxide treatment was used as a positive
control.) Both the benchmark PARP inhibitor 3-aminobenzamide
and the more potent and speciﬁc PARP inhibitor PJ34 prevented
PAR synthesis proving the speciﬁcity of the assays.
In order to more directly assess the role of PARP-1, we silenced
PARP-1 in the human HaCaT keratinocyte cell line (Fig. 4). Expression
of PARP-1 protein (Fig. 4A) and synthesis of PAR polymer in response
to hydrogen peroxide treatment (Fig. 4B) was signiﬁcantly reduced in
the HaCaT-siPARP-1 cells as compared to the parent HaCaT cell line or
the one transfected with control siRNA (HaCaT-siCTL cells). HaCaT
cells displayed a lower sensitivity to UVB (Fig. 4C) than the primary
keratinocytes. Knockdown of PARP-1 resulted in sensitization of the
cells to the toxic effects of UVB (Fig. 4D). 3-Aminobenzamide effec-
tively protected both HaCaT-siPARP-1 cells and HaCaT cells
transfected with control siRNAs (HaCaT-siCTL cells) from UVB toxici-
ty (Fig. 4D). These data indicate that the photoprotective effects of
3AB are not due to PARP inhibition.
3.5. The photoprotective effect of 3AB is not restricted to UVB radiation
In order to ﬁnd out whether our ﬁndings are restricted to
UVB-irradiated cells, we have also investigated the effects of 3AB
and PJ34 in the UVA response of keratinocytes. UVA-induced cell
death was also differently regulated by 3AB and PJ34. Whereas PJ34
enhanced, 3AB suppressed UVA-induced loss of viability (Fig. 5A),
Fig. 4. Silencing PARP-1 sensitizes HaCaT human keratinocytes to UVB-induced toxicity. PARP-1 expression was suppressed in HaCaT cells by siRNAs. (A) Efﬁcient silencing was
conﬁrmed by Western blot analysis. (B) In order to functionally characterize the effect of silencing, we treated the parent cell line (HaCaT), the PARP-1 silenced cells
(HaCaT-siPARP-1) and the cells transfected with control siRNA (HaCaT-siCTL) with hydrogen peroxide. Hydrogen peroxide induced poly(ADP-ribose) accumulation was detected
by Western blotting. (C) Viability of HaCaT cells 24 h after UVB irradiation was determined with MTT assay. (D) The effect of UVB on the viability of the HaCaT-siCTL and
HaCaT-siPARP-1 cells was compared. After pretreatment with 3AB (3 mM) cells were irradiated with UVB (0.05 J/cm2–0.2 J/cm2), incubated for 24 h and viability was determined
in MTT assay. PARP-1 silencing sensitized the cells against UVB irradiation with 3AB having protected both HaCaT-siCTL and HaCaT-siPARP-1 cells. On panel “A–B–D” data are
presented as mean±SE of three independent experiments. On panel “C” data are presented as mean±SD of triplicate samples. Stars represent statistically signiﬁcant (*pb0.05,
**pb0.01, ***pb0.001) difference between HaCaT-siCTL and HaCaT-siPARP-1. “#” symbols indicate statistically signiﬁcant (#pb0.05, ##pb0.01, ###pb0.001) effects of H2O2 (“B”)
or 3AB.
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(Fig. 5B), caspase activation (Fig. 5C), LDH release (Fig. 5D) and
hydrogen peroxide production (Fig. 5E).
4. Discussion
The most important environmental hazard damaging our skin is UV
radiation with the UVB spectrum recognized as the most carcinogenic
portion of solar radiation. Persistent photodamage triggers cell
death in keratinocytes by co-ordinated execution of multiple cell
death pathways [22]. These include a) clustering of death receptors
(Fas, TNFR, TRAIL) initiating the extrinsic apoptotic pathway; and
b) permeabilization of the mitochondrial outer membrane via
ROS production and p38 MAP kinase activation (intrinsic route).
UV-induced DNA damage may also elicit cell death via p53 activa-
tion (also via the intrinsic pathway) [23].
Our hypothesis was that PARylation may represent an important
regulatory mechanism in the UV response. PARylation has previously
been shown in other cellular models to a) enhance cell survival after
DNA damage; b) shift the mode of cell death from apoptosis to necro-
sis following severe DNA damage via NAD+/ATP depletion or AIF
signaling; c) regulate both the p53 and NFκB pathways; d) become
activated via MAP kinases; e) engage in a yet elusive relationship
with the survival pathway mediated by Akt kinase; and f) regulate
cellular metabolic activities [7,24–27]. Since all of these players and
factors have been implicated in the regulation or modulation of theUV response, we set out to investigate the role of PARylation in
UV-induced cell death.
4.1. Role of PARylation in keratinocyte survival following UVB radiation
We found that UVB activates PARylation but PARP activity and the
PAR polymer has only become detectable at very high (2–4 J/cm2) UV
doses. However, it must be noted that the currently available
methods assessing PARylation such as the PARP enzyme activity
assay and detection of PAR polymer may underestimate PARP enzyme
activity. The reason for this is that PARG may mask low level PARP
activity by degrading the polymer that is detected in both assays
used in the current study (PAR immunocytochemistry and PARP
enzyme assay). In fact, the sensitizing effect of PJ34 or the knockdown
of PARP-1 to apoptosis indicates that PARP-1 is activated at low UVB
doses and may contribute to cell survival. Moreover, in other cell
types we have also observed that PARG silencing increases the sensi-
tivity of PAR detection/PARP activity [28] providing further support
for our hypothesis that PARP is “latently” activated by lower UVB
doses but this is masked by cellular PARG activity.
In our model, UVB radiation caused cell death with features of
both apoptosis (picnotic nuclei, cell shrinkage and caspase activation)
and necrosis (LDH release). (The latter may be secondary necrosis of
primarily apoptotic cells as often seen in in vitro models). The bench-
mark PARP inhibitor 3AB provided remarkable protection from all of
the cell death parameters measured. However, the more potent and
Fig. 5. 3AB inhibits UVA-induced cell death. NHEK were either left untreated or were pretreated with 10 μM PJ34 or 3 mM 3AB for 30 min followed by irradiation with the indicated
doses of UVA. (A) After 24 h, viability was determined with MTT assay. UVA induced a time- and dose-dependent loss of viability and 3AB protected cells from UVA-induced cell
death. (B) Cells were also stained with May-Grünwald–Giemsa for general morphology and (C) immunostained for cleaved PARP-1. (D) LDH released from irradiated cells was de-
termined from the culture medium. 3AB prevented UVA-induced plasma membrane injury at all UVB doses. (E) Hydrogen peroxide production was determined 60 min after UVA
irradiation. On panel “A–D–E” data are presented as mean±SE of three independent experiments using keratinocytes from different donors. Stars represent statistically signiﬁcant
(*pb0.05, **pb0.01, ***pb0.001) difference between control and UVB-irradiated cells whereas “#” symbols indicate statistically signiﬁcant (#pb0.05, ##pb0.01, ###pb0.001) effects
of 3AB or PJ34 on the UVB-induced response.
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photodamage. On the contrary, PJ34 sensitized cells to apoptosis indi-
cating that PARylation may contribute to the repair of UVB-induced
DNA damage and thus facilitates keratinocyte survival. Since UVB-
induced photoproducts are repaired by nucleotide excision repair
(NER) this may indicate a role of PARylation in NER [4]. Indeed
PARP-1 has been shown to bind to and become activated by thymine
dimers in UV-irradiated ﬁbroblasts [29]. Alternatively, the sensitizing
effect of PJ34 to UVB-induced apoptosis may indicate the formation of
ROS-induced DNA breaks that may be repaired by the PARP-dependent
BER (base excision repair) machinery. The mechanism of UVB-induced
PARP activation and the exact role of PARylation in the repair of
UVB-induced DNA damage may require further investigation.
4.2. Photoprotection by 3-aminobenzamide
Based on themarked difference between the powerful cytoprotection
provided by 3AB and the sensitization to apoptosis by the more potent
and speciﬁc PARP inhibitor PJ34 and other new generation PARP inhibi-
tors, we concluded that the cytoprotective effect of 3AB is not related
to PARP inhibition. The PARP-1 independent nature of this cytoprotective
effect was also supported by our data obtained in PARP-1 silenced HaCaT
cells. These HaCaT-siPARP-1 cells weremore sensitive to the toxic effects
of UVB but 3AB provided signiﬁcant protection to both control and
HaCaT-siPARP-1 cells. These data clearly show that the cytoprotective
effect of 3AB may not be due to PARP inhibition. 3AB is a weak PARP
inhibitor (usually applied in the range of 1–10 mM) and is known to
have additional pharmacological effects. For example it was shown to
a) indirectly affect activation of protein kinase C [30], act on thecytoskeleton [31], scavenge hydroxyl radicals [32] and inhibit cyto-
chrome P450 [33]. Thus 3AB appears to be a multifunctional agent
possessing diverse pharmacological effects. The question arises where
3AB may interfere with cell death signaling in UVB-irradiated
keratinocytes? Mitochondria represent a crucial checkpoint in
the regulation of apoptosis by integrating survival and death sig-
nals [34]. Our data showing that 3AB prevents depolarization of
themitochondrial membrane indicates that 3AB acts at a step proximal
to mitochondrial alterations. Furthermore, 3AB inhibited ROS produc-
tion in UVB-irradiated cells which may explain its UV-protective effect.
ROS production in UVB irradiated keratinocytes requires calciummobi-
lization [35] and 3AB has been shown to suppress ROS-induced calcium
mobilization in other ROSmediated conditions [36]. However, this effect
of 3AB is likely to be due to PARP inhibition as the effect can also be ob-
served in PARP-1 knockout cells or in cells treatedwith other structurally
unrelated PARP inhibitor [21]. The relationship between PARP activation
and calcium signaling is even more complex as calcium signal has also
been shown to be required for PARP activation and PARP-mediated
cell death in oxidatively stressed HaCaT keratinocytes [37] and
other cell types [38].
The absorption spectrum of 3AB has a peak around the wavelength
used for UVB irradiation (312 nm). Thus a sunscreen-like effect may
partially be responsible for the UVB protective effect of 3AB. At
365 nm, however, the compound does not absorb light at all (data
not shown), while it still very efﬁciently protected cells from
UVA-induced damage. Since UVA- and UVB-induced cell death
shared all morphological and biochemical features investigated,
and the effects of the two inhibitors differed both in UVB and
UVA-irradiated keratinocytes, therefore common mechanisms are
750 P. Lakatos et al. / Biochimica et Biophysica Acta 1833 (2013) 743–751likely to underlie cell death induced by UVA and UVB and to mediate
the effects of PJ34 and 3AB. Since UVA was not absorbed by 3AB, the
protective effect of the compound may thus be due to inhibition of a
cell death pathway at a step proximal to mitochondrial dysfunction
rather than acting as sunscreen.
4.3. PARylation in the regulation of the UV response in vivo?
Our results also have interesting in vivo implications. On the one
hand, it may shed new light on the role of PARylation and the possible
use of PARP inhibitors in UV-induced photoinjury, while on the other
hand it suggests that 3AB may be a potential candidate for reducing
photodamage in the skin. PARP inhibitors have been shown to exert
potent anti-inﬂammatory effects in various models of inﬂammation
ranging from shock, ischemia reperfusion injury to arthritis, colitis
and uveitis [7,39]. In many of these models, the cytoprotective
(antinecrotic) effects of PARP inhibitors (or PARP-1 knockout) have
been suggested to be responsible for at least part of the protective ef-
fects [7]. Our data demonstrating a lack of cytoprotection by PARP in-
hibitors in UVB-irradiated keratinocytes indicate that this mechanism
may not be relevant in a putative anti-inﬂammatory effect of PARP in-
hibitors mainly because UVB-induced cell death is not typically ne-
crotic in vivo. Based on the fact that PARP-1 is a co-factor of NF-κB,
the master regulator of inﬂammatory gene expression [40,41], it is
much more likely to be the key factor in the anti-inﬂammatory ef-
fects of PARP inhibitors. So far only one study addressed the role of
PARP in photodamage [42] by using a multifunctional compound
BGP15 that, in addition to possessing nNOS-inducing, HSP-inducing
and insulin sensitizing effects, also inhibits PARP [43–45]. BGP-15
has been shown to reduce acute photodamage in mice [42] but the
underlying mechanism may not be certain due to the diverse effects
of the compound.
Our data also suggest that 3AB may have the potential to reduce
UV-induced photodamage in vivo. By combining its potent and
PARP-independent cytoprotective effect with PARP inhibition-
dependent suppression of inﬂammatory mediators, it may exert
powerful anti-inﬂammatory action. This hypothesis certainly re-
quires further investigations which should also address (conﬁrm
or exclude) the potential mutagenic effect of 3AB resulting from
the inhibition of apoptosis. Although it may be tempting to suggest
that 3AB may be used as a photoprotective agent in vivo, data by
Epstein and Cleaver [46] showing that topical application of 3AB
shortened the time of onset of UVB-induced tumors and increased
the number of tumors urge caution.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbamcr.2012.12.003.
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